Variable | Not suppressed (n = 310) | Suppressed (n = 189) | Crude PR | p-value | adj PR | 95%CI | p-value |
---|---|---|---|---|---|---|---|
Intervention | Â | Â | Â | Â | Â | Â | Â |
 SOC | 129 (73.7) | 46 (26.3) | 1 |  | 1 |  |  |
 IAC | 181 (58.9) | 143 (44.1) | 1.68 |  > 0.001 | 1.22 | 1.01–1.47 | 0.04 |
Age in years | 34.6 (13.1) | 35.1 (12.5) | 1.01 | 0.666 | 1 | 0.99–1.01 | 0.949 |
Sex | Â | Â | Â | Â | Â | Â | Â |
 Male | 113 (36.5) | 61 (32.3) | 1 |  | 1 |  |  |
 Female | 197 (63.6) | 128 (67.7) | 1.12 | 0.349 | 1.06 | 0.08–1.28 | 0.559 |
Marital status | Â | Â | Â | Â | Â | Â | Â |
 Married | 150 (48.4) | 110 (58.2) | 1 |  |  |  |  |
 Single | 133 (42.9) | 65 (34.4) | 0.78 | 0.042 |  |  |  |
 Children | 27 (8.7) | 14 (7.4) | 0.81 | 0.349 |  |  |  |
CD4 count | Â | Â | Â | Â | Â | Â | Â |
 ≤ 500 | 226 (87.6) | 120 (80.4) | 1 |  |  |  |  |
 > 500 | 32 (12.4) | 29 (19.5) | 1.37 | 0.04 |  |  |  |
First viral load | 43,982 (35,011.1) | 34,107.7 (18,072.5) | 0.99 | 0.496 | Â | Â | Â |
Initial regimen | Â | Â | Â | Â | Â | Â | Â |
 Efavirenz-based regimen | 178 (57.4) | 138 (73.0) | 1 |  |  |  |  |
 Non-Efavirenz-based regimen | 132 (42.6) | 51 (27.0) | 0.64 | 0.001 |  |  |  |
Current regimen | Â | Â | Â | Â | Â | Â | Â |
 NNRTI | 13 (4.2) | 97 (51.3) | 1 |  | 1 |  |  |
 Protease inhibitors (PI) | 285 (91.9) | 29 (15.3) | 0.1 |  < 0.001 | 0.11 | 0.08–0.15 |  < 0.001 |
 DTG-based regimen | 12 (3.9) | 63 (33.3) | 0.95 | 0.429 | 0.96 | 0.85–1.09 | 0.543 |
First detectable viral load | 70,203.2 (199,420.7) | 90,402.5 (289,995.8) | 1 | 0.32 | Â | Â | Â |
Days on ART | 1131.3 (1034.2) | 1053.0 (1005.2) | 0.99 | 0.411 | Â | Â | Â |